Correlation Between AnaptysBio and Champions Oncology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AnaptysBio and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AnaptysBio and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AnaptysBio and Champions Oncology, you can compare the effects of market volatilities on AnaptysBio and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AnaptysBio with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of AnaptysBio and Champions Oncology.

Diversification Opportunities for AnaptysBio and Champions Oncology

0.25
  Correlation Coefficient

Modest diversification

The 3 months correlation between AnaptysBio and Champions is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding AnaptysBio and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and AnaptysBio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AnaptysBio are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of AnaptysBio i.e., AnaptysBio and Champions Oncology go up and down completely randomly.

Pair Corralation between AnaptysBio and Champions Oncology

Given the investment horizon of 90 days AnaptysBio is expected to generate 1.36 times more return on investment than Champions Oncology. However, AnaptysBio is 1.36 times more volatile than Champions Oncology. It trades about 0.02 of its potential returns per unit of risk. Champions Oncology is currently generating about -0.02 per unit of risk. If you would invest  2,533  in AnaptysBio on September 1, 2024 and sell it today you would lose (37.00) from holding AnaptysBio or give up 1.46% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

AnaptysBio  vs.  Champions Oncology

 Performance 
       Timeline  
AnaptysBio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AnaptysBio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Champions Oncology 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Champions Oncology are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating fundamental drivers, Champions Oncology reported solid returns over the last few months and may actually be approaching a breakup point.

AnaptysBio and Champions Oncology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AnaptysBio and Champions Oncology

The main advantage of trading using opposite AnaptysBio and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AnaptysBio position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.
The idea behind AnaptysBio and Champions Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Commodity Directory
Find actively traded commodities issued by global exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like